Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Discover a study that explored the effects of various metabolic abnormalities, such as central obesity and high blood ...

Diabetes drug dapagliflozin could also be beneficial for patients with progressive liver disease, a clinical trial has shown.

The Global Liver Institute urges worldwide integration of liver health into diabetes and obesity care as steatotic liver ...

Follow-up reached a median 5.5 years overall. Adverse liver outcomes in question counted cirrhosis, decompensation, ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

Fatty liver disease is emerging as a serious health issue in India, with rising cases among both adults and children. Often symptomless in its early stages, the condition can quietly progress to ...

A new study reveals that dapagliflozin, a common diabetes medication, could significantly improve conditions like metabolic ...

Learn about 5 liver infections that can hide in your body for decades without symptoms. Discover warning signs and prevention ...

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authoritiesLUND, ...

Genomenon, a leading genomic intelligence company, today announced its pivotal role in a newly published study in the Journal of Lipid Research that significantly advances scientific understanding and ...